Is 4-HO-MET (Metocin) Legal in Nevada? (2026)

Instrument

statute

Source

https://regulations.justia.com/states/nevada/chapter-453/schedules-of-controlled-substances/section-453-510

Retrieved

2026-06-19

Fingerprint

80dbac12963598e9

**NAC 453.510(4) (hallucinogen chapeau + isomer definition)** — "Unless specifically excepted or unless listed in another schedule, any material, compound, mixture or preparation which contains any quantity of the following hallucinogenic substances, including, without limitation, their salts, isomers and salts of isomers, whenever the existence of such salts, isomers and salts of isomers is possible within the specific chemical designation: … For the purposes of this subsection, 'isomer' includes, without limitation, the optical, position or geometric isomer."
— NAC 453.510(4), https://regulations.justia.com/states/nevada/chapter-453/schedules-of-controlled-substances/section-453-510 (MIRROR: Justia regulations, current through Sept. 16, 2024). The list names Psilocin, Psilocybin, DET, DMT, Bufotenine, 5-MeO-DiPT, and 4-AcO-DMT — but **not** 4-HO-MET / 4-hydroxy-N-methyl-N-ethyltryptamine.
**NRS 453.043 (controlled substance analog)** — "'Controlled substance analog' means a substance the chemical structure of which is substantially similar to the chemical structure of a controlled substance placed in schedule I or II and: (a) Which has a stimulant, depressant or hallucinogenic effect on the central nervous system substantially similar to the stimulant, depressant or hallucinogenic effect on the central nervous system of a controlled substance placed in schedule I or II pursuant to NRS 453.166 or 453.176; or (b) With respect to a particular person, which he or she represents or intends to have a stimulant, depressant or hallucinogenic effect on the central nervous system substantially similar to [that] of a controlled substance included in schedule I or II."
— NRS 453.043(1), https://nevada.public.law/statutes/nrs_453.043 (MIRROR: public.law).

Instrument

Controlled substance analog defined; treatment as a substance in Schedule I

Source

https://www.leg.state.nv.us/nrs/nrs-453.html

Retrieved

2026-07-20

Fingerprint

44ee6d0a06f6fb5b

NRS 453.043  "Controlled substance analog" defined.
1. "Controlled substance analog" means a substance the chemical structure of which is substantially similar to the chemical structure of a controlled substance placed in schedule I or II and:
(a) Which has a stimulant, depressant or hallucinogenic effect on the central nervous system substantially similar to the stimulant, depressant or hallucinogenic effect on the central nervous system of a controlled substance placed in schedule I or II pursuant to NRS 453.166 or 453.176; or
(b) With respect to a particular person, which he or she represents or intends to have a stimulant, depressant or hallucinogenic effect on the central nervous system substantially similar to the stimulant, depressant or hallucinogenic effect on the central nervous system of a controlled substance included in schedule I or II.
2. The term does not include:
(a) A controlled substance;
(b) A substance for which there is an approved new drug application;
(c) A substance with respect to which an exemption is in effect for investigational use by a particular person under Section 505 of the federal Food, Drug, and Cosmetic Act (21 U.S.C. 355) to the extent conduct with respect to the substance is permitted by the exemption; or
(d) Any substance to the extent not intended for human consumption before an exemption takes effect with respect to the substance.

NRS 453.219  Controlled substance analog: Treatment as substance in schedule I; notice of prosecution; determination by Board.
A controlled substance analog, to the extent intended for human consumption, must be treated, for the purposes of NRS 453.011 to 453.552, inclusive, as a substance included in schedule I. Within 30 days after the initiation of prosecution with respect to a controlled substance analog by indictment or information, the district attorney shall notify the Board of information relevant to scheduling by extraordinary regulation as provided for in NRS 453.2184. If the Board finally determines that the controlled substance analog should not be scheduled, no prosecution relating to that substance as a controlled substance analog may be commenced or continued.